Early Pregnancy Plasma Per- and Polyfluoroalkyl Substances (PFAS) and Maternal Midlife Adiposity.
Jordan A BurdeauBriana Joy K StephensonJorge E ChavarroShruthi MahalingaiahEmma V PrestonMarie-France HivertEmily OkenAntonia M CalafatSheryl L Rifas-ShimanAmi R ZotaTamarra M James-ToddPublished in: The Journal of clinical endocrinology and metabolism (2024)
Select PFAS, assessed in pregnancy, may differentially affect maternal midlife adiposity, influencing later-life maternal cardiometabolic health.